TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2014-04611
- Event Type
- Injury
- Date Received
- August 12, 2014
- Date of Event
- April 4, 2011
- Report Date
- July 14, 2014
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
SAME CASE AS MFR: 2134265-2014-04613. (B)(4). IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED STENT THROMBOSIS AND SUBSEQUENT MYOCARDIAL INFARCTION. IN (B)(6) 2011, THE PATIENT PRESENTED WITH UNSTABLE ANGINA, BRAUNWALD CLASSIFICATION- IIIB, WHICH WAS DIAGNOSED AS A MYOCARDIAL INFARCTION (MI). CORONARY ANGIOGRAPHY REVEALED STENT THROMBOSIS OF AN UNSPECIFIED BSC STENT IN THE OSTIAL LEFT ANTERIOR DESCENDING (LAD) ARTERY AND A TOTAL OCCLUSION OF AN UNSPECIFIED BSC STENT IN THE MID LAD. TARGET LESION #1 WAS A BIFURCATED, TOTAL OCCLUSION LOCATED WITHIN THE BSC STENT IN THE MID LAD. THE LESION WAS 12MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.5MM. THIS LESION WAS TREATED WITH THROMBOSUCTION, PRE-DILATATION AND PLACEMENT OF A 2.50 MM X 16 MM PROMUS ELEMENT STENT. FOLLOWING POST DILATATION, RESIDUAL STENOSIS WAS 0%. TARGET LESION #2 WAS A TOTAL OCCLUSION LOCATED WITHIN THE BSC STENT IN THE PROXIMAL LAD. THE LESION WAS 20MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.0MM. THIS LESION WAS TREATED WITH PRE-DILATATION AND PLACEMENT OF A 3.00 MM X 20 MM PROMUS ELEMENT STENT. FOLLOWING POST DILATATION, RESIDUAL STENOSIS WAS 10%. THREE DAYS POST PROCEDURE THE PATIENT WAS DISCHARGED ON ASPIRIN AND CLOPIDOGREL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 479820 | TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | UNK433 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 84 YR | Required Intervention |